A previous study in patients with NSCLC found that tumours with high levels of IGFBP-3 displayed more obvious activation of insulin-like growth factor 1 receptor (IGF-1R), indicating that IGFBP3 potentiates the activation of IGF-1R to some extent 45. Here, IGF1R is linked to neoplasm.